Tecnologia educacional na gestão de cuidados: perfil tecnológico de enfermeiros de hospitais portugueses

RESUMO Objetivo Identificar o perfil tecnológico de enfermeiros de hospitais portugueses. Método Estudo exploratório quantitativo, realizado em dois hospitais da região norte e um da região central de Portugal. A amostra foi aleatória e contou com960 enfermeiros. Resultados Dos partícipes 420 (46,1%) utilizavam ocomputador, 196 (23,4%) referiram que têm conhecimento da utilização do computador para o ensino, 174 (21,1%)utilizaram o computador para ensino, 112 (15,1%) reconhecem que a utilização do computador pode ser um meio tecnológico para completar a formação presencial, 477 (61,6%) gostariam de receber formação sobre a utilização do computador e 382 (40,9%) referiram autoaprendizagem em informática. Em relação ao ensino a distância 706 (74,9%) relataram que não estão familiarizados e 752 (76,4%) referiram interesseem participar em formaçõesnesta modalidade. Conclusão As organizações devem estar atentas ao perfil tecnológico que se desenha neste grupo de enfermeiros e procurar formas de introduzir as tecnologias educacionais na gestão de cuidados.

Kirsti Siru 14.10.1969 Helsingfors

Kirje

Biblia [Vetus et Novum Testamentum].

La Bible s’ouvre par deux compositions poétiques d’Alcuin qui encadrent l’Épître de saint Jérôme à Paulinus, « Frater Ambrosius... » (ff. 1-2r : Monumenta Germaniae Historica, Poetae latinae, I, 1, p. 287, LXVIII-LXX, v. 1-200 ; ff. 4r-v : Monumenta Germaniae Historica, Poetae latinae, I, 1, p. 283-284, LXV, I-III). La fin manque: la Bible s'interrompt à la fin de l'Epître de saint Paul aux Colossiens.

Väestön toimeentuloa vaarantavat rikokset, 2K

Puhe

IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25.

IL-2 is crucial to T cell homeostasis, especially of CD4(+) T regulatory cells and memory CD8(+) cells, as evidenced by vigorous proliferation of these cells in vivo following injections of superagonist IL-2/anti-IL-2 antibody complexes. The mechanism of IL-2/anti-IL-2 antibody complexes is unknown owing to a lack of understanding of IL-2 homeostasis. We show that IL-2 receptor alpha (CD25) plays a crucial role in IL-2 homeostasis. Thus, prolongation of IL-2 half-life and blocking of CD25 using antibodies or CD25-deficient mice led in combination, but not alone, to vigorous IL-2-mediated T cell proliferation, similar to IL-2/anti-IL-2 antibody complexes. These data suggest an unpredicted role for CD25 in IL-2 homeostasis.

Traité de l'existence et des attributs de Dieu (Nouvelle édition, accompagnée de notes et précédée d'une introduction et d'une analyse des chapitres, par M. Alph. Aulard,...) / par Fénelon

[Traité de l'existence de Dieu (français). 1878]

Concepts of metastasis in flux: the stromal progression model.

The ability of tumor cells to leave a primary tumor, to disseminate through the body, and to ultimately seed new secondary tumors is universally agreed to be the basis for metastasis formation. An accurate description of the cellular and molecular mechanisms that underlie this multistep process would greatly facilitate the rational development of therapies that effectively allow metastatic disease to be controlled and treated. A number of disparate and sometimes conflicting hypotheses and models have been suggested to explain various aspects of the process, and no single concept explains the mechanism of metastasis in its entirety or encompasses all observations and experimental findings. The exciting progress made in metastasis research in recent years has refined existing ideas, as well as giving rise to new ones. In this review we survey some of the main theories that currently exist in the field, and show that significant convergence is emerging, allowing a synthesis of several models to give a more comprehensive overview of the process of metastasis. As a result we postulate a stromal progression model of metastasis. In this model, progressive modification of the tumor microenvironment is equally as important as genetic and epigenetic changes in tumor cells during primary tumor progression. Mutual regulatory interactions between stroma and tumor cells modify the stemness of the cells that drive tumor growth, in a manner that involves epithelial-mesenchymal and mesenchymal-epithelial-like transitions. Similar interactions need to be recapitulated at secondary sites for metastases to grow. Early disseminating tumor cells can progress at the secondary site in parallel to the primary tumor, both in terms of genetic changes, as well as progressive development of a metastatic stroma. Although this model brings together many ideas in the field, there remain nevertheless a number of major open questions, underscoring the need for further research to fully understand metastasis, and thereby identify new and effective ways of treating metastatic disease.

Le monde physique : essai de conception expérimentale / par le Dr Julien Pioger

Collection : Bibliothèque de philosophie contemporaine

Johtaja Pekka Martin 26/2 1973

Kirje 26.2.1973

Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses.

Group 3 innate lymphoid cells (ILC3s) have emerged as important cellular players in tissue repair and innate immunity. Whether these cells meaningfully regulate adaptive immune responses upon activation has yet to be explored. Here we show that upon IL-1β stimulation, peripheral ILC3s become activated, secrete cytokines, up-regulate surface MHC class II molecules, and express costimulatory molecules. ILC3s can take up latex beads, process protein antigen, and consequently prime CD4(+) T-cell responses in vitro. The cognate interaction of ILC3s and CD4(+) T cells leads to T-cell proliferation both in vitro and in vivo, whereas its disruption impairs specific T-cell and T-dependent B-cell responses in vivo. In addition, the ILC3-CD4(+) T-cell interaction is bidirectional and leads to the activation of ILC3s. Taken together, our data reveal a novel activation-dependent function of peripheral ILC3s in eliciting cognate CD4(+) T-cell immune responses.